Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Letai

Showing results (21-30 of 182) with videos related to

Pageof 19
Sort By:
Current Molecular Medicine|March 14, 2008
Regulation of Bcl-2 family proteins by posttranslational modificationsOzgur Kutuk, Anthony Letai
Molecular & Cellular Oncology|June 18, 2016
Dynamic BH3 profiling-poking cancer cells with a stickJoan Montero, Anthony Letai
Methods (San Diego, Calif.)|April 24, 2013
BH3 profiling in whole cells by fluorimeter or FACSJeremy Ryan, Anthony Letai
Blood|July 25, 2018
BCL-2 inhibition in AML: an unexpected bonus?Marina Konopleva, Anthony Letai
Cancer Cell|February 16, 2013
ABT-199: taking dead aim at BCL-2Matthew S Davids, Anthony Letai
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2012
Targeting the B-cell lymphoma/leukemia 2 family in cancerMatthew S Davids, Anthony Letai
Molecular Cell|March 5, 2016
Mitochondria-Judges and Executioners of Cell Death SentencesPatrick D Bhola, Anthony Letai
Nature Reviews. Cancer|December 16, 2024
Conventional chemotherapy: millions of cures, unresolved therapeutic indexAnthony Letai, Hugues de The
Advances in Experimental Medicine and Biology|October 6, 2010
BH3-only proteins and their effects on cancerThanh-Trang Vo, Anthony Letai
Molecular Cell|December 27, 2011
Who put the "A" in Atg12: autophagy or apoptosis?Triona Ni Chonghaile, Anthony Letai
Pageof 19

Showing results (21-30 of 182) with videos related to

Sort By:
Pageof 19
Current Molecular Medicine|March 14, 2008
Regulation of Bcl-2 family proteins by posttranslational modificationsOzgur Kutuk, Anthony Letai
Molecular & Cellular Oncology|June 18, 2016
Dynamic BH3 profiling-poking cancer cells with a stickJoan Montero, Anthony Letai
Methods (San Diego, Calif.)|April 24, 2013
BH3 profiling in whole cells by fluorimeter or FACSJeremy Ryan, Anthony Letai
Blood|July 25, 2018
BCL-2 inhibition in AML: an unexpected bonus?Marina Konopleva, Anthony Letai
Cancer Cell|February 16, 2013
ABT-199: taking dead aim at BCL-2Matthew S Davids, Anthony Letai
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2012
Targeting the B-cell lymphoma/leukemia 2 family in cancerMatthew S Davids, Anthony Letai
Molecular Cell|March 5, 2016
Mitochondria-Judges and Executioners of Cell Death SentencesPatrick D Bhola, Anthony Letai
Nature Reviews. Cancer|December 16, 2024
Conventional chemotherapy: millions of cures, unresolved therapeutic indexAnthony Letai, Hugues de The
Advances in Experimental Medicine and Biology|October 6, 2010
BH3-only proteins and their effects on cancerThanh-Trang Vo, Anthony Letai
Molecular Cell|December 27, 2011
Who put the "A" in Atg12: autophagy or apoptosis?Triona Ni Chonghaile, Anthony Letai
Pageof 19